✦ LIBER ✦

Further information on motavizumab required by US FDA.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

US FDA requests additional information o

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Amendment of brandname-drug patent requi

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Uncertainty regarding exemption from inf

✍ Grossman, Jonathan E; Hanish, John P 📂 Article 📅 2013 🏛 Newlands Press Ltd 🌐 English ⚖ 596 KB

US drug approval may be slowed by increa

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

FDA perspectives on supplement use by pa

✍ Myong-Jin Kim 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Further inflammatory information on meta

✍ Kunihiro Matsushita; Koji Tamakoshi; Hiroshi Yatsuya; Keiko Wada; Rei Otsuka; Se 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 195 KB